Medtronic plc (LON:0Y6X)
London
· Delayed Price · Currency is GBP · Price in USD 81.26
+0.85 (1.05%)
At close: May 27, 2025
Medtronic Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | 2016 - 2020 |
| Revenue | 33,537 | 32,364 | 31,227 | 31,686 | 30,117 | Upgrade
|
| Revenue Growth (YoY) | 3.62% | 3.64% | -1.45% | 5.21% | 4.16% | Upgrade
|
| Cost of Revenue | 11,568 | 11,091 | 10,622 | 10,028 | 10,355 | Upgrade
|
| Gross Profit | 21,969 | 21,273 | 20,605 | 21,658 | 19,762 | Upgrade
|
| Selling, General & Admin | 10,779 | 10,183 | 10,004 | 10,047 | 9,956 | Upgrade
|
| Research & Development | 2,732 | 2,735 | 2,696 | 2,746 | 2,493 | Upgrade
|
| Other Operating Expenses | -48 | 253 | 429 | 285 | 40 | Upgrade
|
| Operating Expenses | 15,270 | 14,864 | 14,827 | 14,811 | 14,272 | Upgrade
|
| Operating Income | 6,699 | 6,409 | 5,778 | 6,847 | 5,490 | Upgrade
|
| Interest Expense | -729 | -719 | -583 | -553 | -925 | Upgrade
|
| Interest & Investment Income | - | 597 | 386 | 186 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 176 | 672 | 198 | -230 | Upgrade
|
| Other Non Operating Income (Expenses) | 613 | -293 | 68 | 36 | 340 | Upgrade
|
| EBT Excluding Unusual Items | 6,583 | 6,170 | 6,321 | 6,714 | 4,675 | Upgrade
|
| Merger & Restructuring Charges | -303 | -1,166 | -878 | -1,110 | -617 | Upgrade
|
| Impairment of Goodwill | - | - | -61 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -213 | - | 56 | 8 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -75 | - | - | Upgrade
|
| Legal Settlements | -317 | -149 | 30 | -95 | -118 | Upgrade
|
| Other Unusual Items | -123 | -18 | -29 | - | - | Upgrade
|
| Pretax Income | 5,627 | 4,837 | 5,364 | 5,517 | 3,895 | Upgrade
|
| Income Tax Expense | 936 | 1,133 | 1,580 | 456 | 265 | Upgrade
|
| Earnings From Continuing Operations | 4,691 | 3,704 | 3,784 | 5,061 | 3,630 | Upgrade
|
| Minority Interest in Earnings | -29 | -28 | -26 | -22 | -24 | Upgrade
|
| Net Income | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 | Upgrade
|
| Net Income to Common | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 | Upgrade
|
| Net Income Growth | 26.82% | -2.18% | -25.42% | 39.74% | -24.70% | Upgrade
|
| Shares Outstanding (Basic) | 1,286 | 1,328 | 1,330 | 1,342 | 1,345 | Upgrade
|
| Shares Outstanding (Diluted) | 1,290 | 1,330 | 1,333 | 1,351 | 1,354 | Upgrade
|
| Shares Change (YoY) | -3.03% | -0.19% | -1.38% | -0.19% | 0.21% | Upgrade
|
| EPS (Basic) | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 | Upgrade
|
| EPS (Diluted) | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 | Upgrade
|
| EPS Growth | 30.80% | -2.13% | -24.40% | 40.23% | -24.86% | Upgrade
|
| Free Cash Flow | 5,185 | 5,200 | 4,580 | 5,978 | 4,885 | Upgrade
|
| Free Cash Flow Per Share | 4.02 | 3.91 | 3.44 | 4.42 | 3.61 | Upgrade
|
| Dividend Per Share | 2.800 | 2.760 | 2.720 | 2.520 | 2.320 | Upgrade
|
| Dividend Growth | 1.45% | 1.47% | 7.94% | 8.62% | 7.41% | Upgrade
|
| Gross Margin | 65.51% | 65.73% | 65.98% | 68.35% | 65.62% | Upgrade
|
| Operating Margin | 19.98% | 19.80% | 18.50% | 21.61% | 18.23% | Upgrade
|
| Profit Margin | 13.90% | 11.36% | 12.03% | 15.90% | 11.97% | Upgrade
|
| Free Cash Flow Margin | 15.46% | 16.07% | 14.67% | 18.87% | 16.22% | Upgrade
|
| EBITDA | 9,560 | 9,056 | 8,475 | 9,554 | 8,192 | Upgrade
|
| EBITDA Margin | 28.51% | 27.98% | 27.14% | 30.15% | 27.20% | Upgrade
|
| D&A For EBITDA | 2,861 | 2,647 | 2,697 | 2,707 | 2,702 | Upgrade
|
| EBIT | 6,699 | 6,409 | 5,778 | 6,847 | 5,490 | Upgrade
|
| EBIT Margin | 19.98% | 19.80% | 18.50% | 21.61% | 18.23% | Upgrade
|
| Effective Tax Rate | 16.63% | 23.42% | 29.46% | 8.27% | 6.80% | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.